Projeto
Biointeration studies of recombinant HPV-16 oncoproteins to discover therapeutic inhibitors
| Referência: | 2020.06792.BD |
|---|---|
| Organização financiadora: | Fundação para a Ciência e a Tecnologia |
| Instituições associadas: | Universidade Nova de Lisboa |
Registos relacionados
Bolsa Doutoramento FCT: Biointeration studies of recombinant HPV-16 oncoproteins to discover therapeutic inhibitors [2020.06792.BD]
Biointeration studies of membrane-bound catechol-O-methyltransferase polymorphic variants with commercial Parkinson’s inhibitors
PLANT developmental biology: discovering the ORIGINS of form
Platform for the biosynthesis and purification of HPV-16 E6/E7mutant DNA vaccine for cervical cancer treatment or prevention
Telomeric R-loop-mediated recombination in the alternative lengthening of telomeres pathway: towards designing novel therapeutic avenues for cancer therapy
Bolsa de Pós-Doutoramento FCT: Platform for the biosynthesis and purification of HPV-16 E6/E7mutant DNA vaccine for cervical cancer treatment or prevention [SFRH/BPD/102716/2014]
Towards the improvement of recombinant proteins bioprocessing using ionic liquids
DREAM - Drug delivery nanosysteM for HPV infection therapy [UTAP-EXPL/NTec/0015/2017]
Discovering New Pathways Underlying ASD: Chromatin Remdoling and Regulation of Gene Expression [SFRH/BD/52049/2012]
TRANSFORMing Aqueous Biphasic Systems (TRANSFORMABS): Continuous Affinity-driven Purification of Recombinant Protein Therapeutics using Bioprivileged Ionic Liquids and Deep Eutectic Solvents
ANTIBODIES AND RECOMBINANT PROTEIN DEVELOPMENT: TOOLS FOR DIAGNOSIS AND IMMUNOPROPHYLAXIS OF INFECTIOUS DISEASES
A study on the interaction among natural selection, mutation and recombination, with Caenorhabditis elegans experimental evolution
Bolsa de Pós-Doutoramento FCT: Purification of HPV-16 E6/E7 DNA vaccine by monolithic chromatography using amino acids and derivatives as affinity ligands for pharmaceutical applications [SFRH/BPD/79106/2011]
Deciphering the role of the serine protease inhibitor SPINT2 managing melanoma tumorigenesis and therapeutic response [2020.05779.BD]
DEVELOPMENT OF INHIBITORS OF DENGUE VIRUS ASSEMBLY
COMPUTATIONAL MODELING OF PHOSPHODIESTERASE 3 INHIBITORS
Lipid-tagged peptides as entry inhibitors for respiratory viruses
BROAD-SPECTRUM FUSION INHIBITORS AGAINST ENVELOPED VIRUSES
Modeling the response to radiation: DNA repair inhibitors and protectors
Modeling the response to radiation: DNA repair inhibitors and protectors
An Innovative Recombinant Hit-Maximization Strategy to Unravel the Structure of Cohesin-Dockerin Complexes of Bacteroides cellulosolvens and Acetivibrio cellulolyticus
CLINICAL AND IMMUNOLOGICAL CHARACTERIZATION OF NATURALLY OCCURRING CANINE LYMPHOMA: DEVELOPMENT AND APPLICATION OF ENGINEERED RECOMBINANT ANTIBODIES FOR DIAGNOSIS AND TREATMENT
MULTI-TARGET HIV ENTRY INHIBITORS DELIVERY BY CATIONIC LIPOSOMES
Engineering fusion inhibitor peptides against childhood respiratory viruses
Multi-target HIV entry inhibitors delivery by cationic liposomes
Development of new inhibitors of invasive osteosarcoma based on fisetin derivatives
Design, synthesis and evaluation of novel potential anti-leishmanial inhibitors
Strategic Project - LA 16 - 2013-2014
Strategic Project - LA 16 - 2011-2012
INNOVATIVE WATER-SOLUBLE PHYTOMATERIAL INHIBITORs FOR ALZHEIMERs AND PARKINSONs DISEASES PREVENTION
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
Development of p53-MDMs Protein-Protein Interaction Inhibitors to Tackle Cancer
Relative effectivity of aromatase inhibitors versus tamoxifen in patients with early breast cancer
Therapeutic deep eutectic systems as promising selective therapeutic agents in the anticancer battle
STUDY OF VIRAL ANTIAPOPTOTIC PROTEINS AS POSSIBLE MOLECULAR THERAPEUTIC TARGETS
Design, bioproduction and characterization of protein recombinant silk-elastin-based polymers – a new class of nano-biomaterials [SFRH/BD/36754/2007]
CD-ROM Edition of Portuguese Theatre of the 16th Century
SYNTHESIS AND COMPUTER-ASSISTED DESIGN OF MITOCHONDRIAL ELECTRON TRANSPORT-CHAIN INHIBITORS AS ANTIMALARIAL AGENTS
NEW SYNTHETIC STRATEGIES AND STRUCTURAL OPTIMIZATION OF THE SUGAR MOIETY FROM A SELECTIVE BUTYRYLCHOLINESTERASE INHIBITOR
Understanding the molecular mechanisms and identifying novel inhibitors of p-gp mediated cancer drug resistance
Publicações relacionadas
Carregando publicações...